BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1681376)

  • 1. Safety of IVIG made from HCV-antibody-screened plasma.
    Schiff P; Kemp A
    Lancet; 1991 Oct; 338(8774):1076. PubMed ID: 1681376
    [No Abstract]   [Full Text] [Related]  

  • 2. Transmission of hepatitis after the administration of intravenous immunoglobulins.
    Rousell RH; Dobkin MB; Budinger MD; Louie RE
    Am J Clin Pathol; 1993 May; 99(5):649. PubMed ID: 8493958
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoglobulins and hepatitis C virus.
    Thomas DP
    Lancet; 1990 Jun; 335(8704):1531. PubMed ID: 1972462
    [No Abstract]   [Full Text] [Related]  

  • 4. The viral safety of intravenous immune globulin.
    Yap PL
    Clin Exp Immunol; 1996 May; 104 Suppl 1():35-42. PubMed ID: 8625542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to hepatitis C virus in human immunoglobulins: clinical meaning and diagnostic difficulties in children undergoing bone marrow transplant.
    Mateos ML; Camarero C; Maldonado S; Lasa E; Otheo E; Muñoz A
    Bone Marrow Transplant; 1994 Jul; 14(1):95-7. PubMed ID: 7524908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major.
    Wonke B; Hoffbrand AV; Brown D; Dusheiko G
    J Clin Pathol; 1990 Aug; 43(8):638-40. PubMed ID: 2119395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Symptomatic mixed cryoglobulinemia containing anti-HCV antibody in a patient with chronic hepatitis C].
    Beauvais C; Berenbaum F; Prier A; Kaplan G
    Presse Med; 1991 Oct; 20(34):1683. PubMed ID: 1836575
    [No Abstract]   [Full Text] [Related]  

  • 8. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jul; 43(28):505-9. PubMed ID: 8022396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    JAMA; 1994 Aug; 272(6):424-5. PubMed ID: 8040966
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C transmission associated with intravenous immunoglobulins.
    Nübling CM; Willkommen H; Löwer J
    Lancet; 1995 May; 345(8958):1174. PubMed ID: 7536875
    [No Abstract]   [Full Text] [Related]  

  • 11. An outbreak of acute hepatitis C among recipients of intravenous immunoglobulin.
    Flora K; Schiele M; Benner K; Montanaro A; Johnston W; Whitham R; Press R
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):160-2. PubMed ID: 8595535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and significance of HCV infection in a consecutive series of patients with HBV antibodies and raised aminotransferases.
    Delle Monache M; Santolamazza M; Marinelli RM; Ricci GL
    Ital J Gastroenterol; 1991; 23(3):140-1. PubMed ID: 1660329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to hepatitis C virus and its modes of transmission in dialysis patients.
    Almroth G; Ekermo B; Franzén L; Hed J
    Nephron; 1991; 59(2):232-5. PubMed ID: 1659671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence of an antigen/antibody system characterizing 1 subgroup of posttransfusion non-A, non-B hepatitis].
    Renger FG; Raabe A; Forster H; Knot E
    Vutr Boles; 1986; 25(5):62-4. PubMed ID: 2433838
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transaminases and histological activity in chronic hepatitis C].
    Zaugg PY; Bernardi M; Schmid M; Havelka J; Bühler H
    Schweiz Med Wochenschr; 1995 Apr; 125(15):719-22. PubMed ID: 7537891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis C antibodies in patients with liver disorders in the west of Ireland.
    Gokulan C; O'Gorman T; Corbett-Feeney G; McCarthy CF
    Ir Med J; 1993 Jan; 86(1):32-3. PubMed ID: 8444595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to hepatitis C virus in children with acute or chronic viral hepatitis.
    Bortolotti F; Tagger A; Cadrobbi P; Crivellaro C; Ribero ML; Alberti A
    Lancet; 1989 Nov; 2(8672):1162. PubMed ID: 2572889
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors and clinical expression of HCV infection in hemodialysis patients.
    Pauri P; Salvoni G; Vitolo W; Carletti P; Fanciulli E; Ricciatti AM; Della Bella S; Mioli VA
    Nephron; 1992; 61(3):313-4. PubMed ID: 1323778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-A, non-B hepatitis: clinical laboratory course in patients on hemodialysis and its correlation with the presence of anti-hepatitis C virus antibodies.
    La Russa A; Bufano G; Cauzzi L; Pecchini P
    Nephron; 1992; 61(3):273-5. PubMed ID: 1323770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HCV false positivity in malaria.
    Aceti A; Taliani G; de Bac C; Sebastiani A
    Lancet; 1990 Dec; 336(8728):1442-3. PubMed ID: 1978891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.